Captrust Financial Advisors Horizon Therapeutics Public LTD CO Transaction History

Captrust Financial Advisors

$30 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $1,682 - $1,967	-17 Reduced 0.38%	4,444 $514,000
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $50,771 - $59,224	527 Added 13.4%	4,461 $458,000
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $131,574 - $139,151	-1,226 Reduced 23.76%	3,934 $429,000
Q4 2022 Feb 15, 2023	BUY	$62.39 - $113.8 $21,337 - $38,919	342 Added 7.1%	5,160 $587,000
Q3 2022 Nov 16, 2022	SELL	$58.92 - $84.67 $195,555 - $281,019	-3,319 Reduced 40.79%	4,818 $298,000

Q2 2022 Aug 23, 2022	SELL	$79.4 - $116.36 $63,361 - $92,855	-798 Reduced 8.93%	8,137 $649,000
Q2 2022 Aug 16, 2022	BUY	$79.4 - $116.36 $207,234 - $303,699	2,610 Added 41.26%	8,935 $713,000
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $119,346 - $151,647	-1,381 Reduced 17.92%	6,325 $665,000
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $68,893 - $83,817	699 Added 9.98%	7,706 $830,000
Q3 2021 Nov 16, 2021	BUY	$91.91 - $110.37 $28,767 - $34,545	313 Added 4.68%	7,007 $768,000
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $146,608 - $163,064	1,700 Added 34.04%	6,694 $627,000
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $285,596 - $379,628	3,976 Added 390.57%	4,994 $460,000
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $1,340 - $1,687	-20 Reduced 1.93%	1,018 $74,000
Q3 2020 Nov 17, 2020	SELL	$55.23 - $79.93 $1,988 - $2,877	-36 Reduced 3.35%	1,038 $83,000
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $32,434 - $61,196	1,074 New	1,074 $59,000
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $6,967 - $10,047	-274 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $3,726 - $4,531	-162 Reduced 37.16%	274 $7,000
Q1 2019 May 15, 2019	BUY	$19.49 - $29.01 $8,497 - $12,648	436 New	436 $12,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account